125 related articles for article (PubMed ID: 30182875)
1. Changes to the World Health Organization guideline on hormonal contraceptive eligibility for women at high risk of HIV: South African perspective and response.
Nene Z; Hofmeyr GJ; Patel M; Panday M; Rees H; Makua M; Pillay Y
S Afr Med J; 2018 Jul; 108(8):629-631. PubMed ID: 30182875
[TBL] [Abstract][Full Text] [Related]
2. Update to U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Updated Recommendations for the Use of Contraception Among Women at High Risk for HIV Infection.
Tepper NK; Curtis KM; Cox S; Whiteman MK
MMWR Morb Mortal Wkly Rep; 2020 Apr; 69(14):405-410. PubMed ID: 32271729
[TBL] [Abstract][Full Text] [Related]
3. Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study.
Byrne EH; Anahtar MN; Cohen KE; Moodley A; Padavattan N; Ismail N; Bowman BA; Olson GS; Mabhula A; Leslie A; Ndung'u T; Walker BD; Ghebremichael MS; Dong KL; Kwon DS
Lancet Infect Dis; 2016 Apr; 16(4):441-8. PubMed ID: 26723758
[TBL] [Abstract][Full Text] [Related]
4. Responding to the ECHO trial results: modelling the potential impact of changing contraceptive method mix on HIV and reproductive health in South Africa.
Smith JA; Beacroft L; Abdullah F; Buthelezi B; Makua M; Morroni C; Ramjee G; Velasquez C; Hallett TB
J Int AIDS Soc; 2020 Oct; 23(10):e25620. PubMed ID: 33030312
[TBL] [Abstract][Full Text] [Related]
5. Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial.
Balkus JE; Brown ER; Hillier SL; Coletti A; Ramjee G; Mgodi N; Makanani B; Reid C; Martinson F; Soto-Torres L; Abdool Karim SS; Chirenje ZM
Contraception; 2016 Jan; 93(1):25-31. PubMed ID: 26519646
[TBL] [Abstract][Full Text] [Related]
6. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
Noguchi LM; Richardson BA; Baeten JM; Hillier SL; Balkus JE; Chirenje ZM; Bunge K; Ramjee G; Nair G; Palanee-Phillips T; Selepe P; van der Straten A; Parikh UM; Gomez K; Piper JM; Watts DH; Marrazzo JM;
Lancet HIV; 2015 Jul; 2(7):e279-87. PubMed ID: 26155597
[TBL] [Abstract][Full Text] [Related]
7. Hormonal contraception and HIV acquisition risk: implications for individual users and public policies.
Jain AK
Contraception; 2012 Dec; 86(6):645-52. PubMed ID: 22541635
[TBL] [Abstract][Full Text] [Related]
8. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection.
Tepper NK; Krashin JW; Curtis KM; Cox S; Whiteman MK
MMWR Morb Mortal Wkly Rep; 2017 Sep; 66(37):990-994. PubMed ID: 28934178
[TBL] [Abstract][Full Text] [Related]
9. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection or infected with HIV.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Jun; 61(24):449-52. PubMed ID: 22717514
[TBL] [Abstract][Full Text] [Related]
10. Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial.
Hofmeyr GJ; Singata-Madliki M; Lawrie TA; Bergel E; Temmerman M
Reprod Health; 2016 Apr; 13():42. PubMed ID: 27091008
[TBL] [Abstract][Full Text] [Related]
11. Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.
Hapgood JP; Kaushic C; Hel Z
Endocr Rev; 2018 Feb; 39(1):36-78. PubMed ID: 29309550
[TBL] [Abstract][Full Text] [Related]
12. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
13. Planning for Outcomes (P
Lebetkin E; Gao X; Taylor D; Maldonado LY; Saad A; Steiner MJ; Dorflinger LJ; Nanda K; Mastro TD
Glob Health Sci Pract; 2019 Jun; 7(2):317-328. PubMed ID: 31189699
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa.
Myer L; Denny L; Wright TC; Kuhn L
Int J Epidemiol; 2007 Feb; 36(1):166-74. PubMed ID: 17175547
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Contraception; 1998 May; 57(5):315-24. PubMed ID: 9673838
[TBL] [Abstract][Full Text] [Related]
16. [Current status of the female condom in Africa].
Deniaud F
Sante; 1997; 7(6):405-15. PubMed ID: 9503499
[TBL] [Abstract][Full Text] [Related]
17. Perspectives on contraceptive implant use in women living with HIV in Cape Town, South Africa: a qualitative study among primary healthcare providers and stakeholders.
Brown A; Harries J; Cooper D; Morroni C
BMC Public Health; 2019 Jul; 19(1):1003. PubMed ID: 31349786
[TBL] [Abstract][Full Text] [Related]
18. The WHO's medical eligibility criteria for contraceptive use: 20 years of global guidance.
Altshuler AL; Gaffield ME; Kiarie JN
Curr Opin Obstet Gynecol; 2015 Dec; 27(6):451-9. PubMed ID: 26390246
[TBL] [Abstract][Full Text] [Related]
19. The Food and Drug Administration and medroxyprogesterone acetate. What are the issues?
Rosenfield A; Maine D; Rochat R; Shelton J; Hatcher RA
JAMA; 1983 Jun; 249(21):2922-8. PubMed ID: 6221125
[TBL] [Abstract][Full Text] [Related]
20. Hormonal contraception and the risk of HIV acquisition among women in South Africa.
Morrison CS; Skoler-Karpoff S; Kwok C; Chen PL; van de Wijgert J; Gehret-Plagianos M; Patel S; Ahmed K; Ramjee G; Friedland B; Lahteenmaki P
AIDS; 2012 Feb; 26(4):497-504. PubMed ID: 22156973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
